Log in to save to my catalogue

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmal...

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b1d5a26130fa4ac4b29586136934a317

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia

About this item

Full title

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia

Publisher

Public Library of Science (PLoS)

Journal title

PloS one, 2022-01, Vol.17 (9), p.e0274774

Language

English

Formats

Publication information

Publisher

Public Library of Science (PLoS)

More information

Scope and Contents

Contents

Methylmalonic acidemia (MMA) is an inborn error of metabolism mostly caused by mutations in the mitochondrial methylmalonyl-CoA mutase gene (MMUT). MMA patients suffer from frequent episodes of metabolic decompensation, which can be life threatening. To mimic both the dietary restrictions and metabolic decompensation seen in MMA patients, we develo...

Alternative Titles

Full title

Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b1d5a26130fa4ac4b29586136934a317

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b1d5a26130fa4ac4b29586136934a317

Other Identifiers

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0274774

How to access this item